Non alcoholic fatty liver disease in southern Iran: a population based study
- PMID: 23922564
- PMCID: PMC3734894
- DOI: 10.5812/hepatmon.9248
Non alcoholic fatty liver disease in southern Iran: a population based study
Abstract
Background: Population based studies on prevalence and risk factors of NAFLD in Iranian population are few. The prevalence of NAFLD and non alcoholic steatohepatitis (NASH) in Iranians varies from 2.9% to 7.1% in general population and 55.8% in patients with type 2 diabetes mellitus.
Objectives: To determine the prevalence and determinants of non alcoholic fatty liver disease (NAFLD) in a sample of adult Iranian general population.
Patients and methods: This was a cross-sectional study being performed in Shiraz, southern Iran during a 10-month period from November 2010 to September 2011 through cluster random sampling of Iranian general population in Shiraz region. All individuals undergone anthropometric, blood pressure measurements, thorough medical history and physical examinations. Laboratory measurements included fasting blood glucose (FBS), lipid profile, complete blood count (CBC) and liver function tests. NAFLD was diagnosed by transabdominal ultrasonography.
Results: 819 subjects were included in this study among which were 340 males (41.5%) and 479 females (58.5%) with the mean age of 43.1 ± 14.1 years. NAFLD was diagnosed in 176 (21.5%) subjects. Patients with NAFLD were significantly older (P < 0.001), had higher proportion of male gender (P = 0.004) and had higher BMI (P < 0.001). They also had higher prevalence of hypertension (P < 0.001), high FBS (P < 0.001), high cholesterol (P = 0.026), high triglyceride (P < 0.001) and high waist circumference (P < 0.001). Taking all these together, patients with NAFLD had significantly higher prevalence of metabolic syndrome when compared to healthy subjects (P < 0.001).
Conclusion: The prevalence of NAFLD in this group of Iranian adult general population is 21.5%. NAFLD in Iranian population is associated with male gender, old age, obesity, and features of metabolic syndrome.
Keywords: Iran; Metabolic Syndrome; Non alcoholic Fatty Liver Disease; Prevalence; Risk Factors.
Similar articles
-
Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.Arch Iran Med. 2017 Apr;20(4):211-217. Arch Iran Med. 2017. PMID: 28412824
-
Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study.BMC Gastroenterol. 2024 Jun 26;24(1):212. doi: 10.1186/s12876-024-03302-y. BMC Gastroenterol. 2024. PMID: 38926664 Free PMC article.
-
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P. Vojnosanit Pregl. 2016. PMID: 29327896
-
Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.Int J Organ Transplant Med. 2016;7(3):149-160. Epub 2016 Aug 1. Int J Organ Transplant Med. 2016. PMID: 27721961 Free PMC article. Review.
-
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4. J Hepatol. 2019. PMID: 31279902
Cited by
-
Mediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study.J Nutr Sci. 2021 Jul 26;10:e55. doi: 10.1017/jns.2021.43. eCollection 2021. J Nutr Sci. 2021. PMID: 34367629 Free PMC article.
-
Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients.Avicenna J Med Biotechnol. 2017 Jul-Sep;9(3):155-161. Avicenna J Med Biotechnol. 2017. PMID: 28706613 Free PMC article.
-
Predictors of Nonalcoholic Fatty Liver Disease Among Middle-Aged Iranians.Int J Prev Med. 2020 Aug 6;11:113. doi: 10.4103/ijpvm.IJPVM_274_19. eCollection 2020. Int J Prev Med. 2020. PMID: 33088441 Free PMC article.
-
The Association between Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Non-alcoholic Fatty Liver Disease and Its Severity.Middle East J Dig Dis. 2018 Apr;10(2):96-104. doi: 10.15171/mejdd.2018.97. Epub 2018 Mar 23. Middle East J Dig Dis. 2018. PMID: 30013758 Free PMC article.
-
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3. Trials. 2017. PMID: 28592311 Free PMC article. Clinical Trial.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources